Home
Shukra Pharmaceuticals Ltd Share Price History
Shukra Pharmaceuticals Ltd
BSE : 16 Apr, 2025
20.521.0 (5.0%)
Prev Close
19.5
Open Price
20.5
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
859773
Today's High / Low
20.5 / 18.6
52 WK High / Low
27.1 / 5.8
Market Price of Shukra Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Shukra Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 5 |
| Sales YoY Gr. | - |
| Adj EPS | 3.21 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1 |
| BVPS | 93.1 |
Key Financial Parameters
| Parameter | 2016 |
|---|---|
| Return on Capital Emp. % | 6.28 |
| Op. Profit Mgn % | 28.25 |
| Net Profit Mgn % | 6.39 |
| Debt to Equity % | 0.04 |
Latest Shareholding
Promoters Holdings Over Time
About Shukra Pharmaceuticals Ltd
- Shukra Pharmaceuticals Limited (Formerly known Relish Pharmaceuticals Limited) was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016.
- The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele.
- Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.
Popular Search
FAQs for Shukra Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Shukra Pharmaceuticals Ltd's share price history?
Key events that impact Shukra Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Shukra Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Shukra Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Shukra Pharmaceuticals Ltd?
Dividends can influence Shukra Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Shukra Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Shukra Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Shukra Pharmaceuticals Ltd’s share price history?
To understand Shukra Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
